Life-Sciences-UK.com
The British Life Sciences Web Portal

This is a free web portal for the life sciences in the UK and Ireland... » read more

Astex & Genentech: Collaboration & License Agreement (2026-07-06)
> Collaboration leverages Astex’s industry-leading, fragment-based drug discovery capability to target a key cell-cycle-dependent regulator in breast cancer > Astex to receive an upfront and potential milestone payments, totalling more than $490 million as wel...
Novartis Acquires Myricx Bio for up to $1.5b; $1.1b Upfront (2026-07-06)
> Adds potential first-in-class, N-myristoyltransferase inhibitor (NMTi) antibody-drug conjugate (ADC) payload platform, designed to address resistance to current payloads > Strengthens the Novartis oncology pipeline with two lead ADC assets and a broader payloa...
Klick Health Acquires Oxford PharmaGenesis (2026-06-30)
Bonded by breakthroughs and a laser focus on their people and clients, leading independent agencies join forces to deliver accelerated commercial success through broadened medical affairs and communications, market access, and RWE/HEOR offerings; the most advanced ...
Merck KGaA to Acquire Bio-Techne for $11.3b (€9.9b) (2026-06-25)
> Purchase price of US$73 per share in cash represents an enterprise value of US$11.3 billion (EUR 9.9 billion) > Proposed acquisition expected to be immediately accretive to sales growth and EBITDA pre margin post-closing, and EPS pre accretive by year 3 after ...
Coulter Partners Places Vincent Metzler as CEO of Cellcolabs (2026-06-23)
Coulter Partners successfully led a search for Cellcolabs and is pleased to announce the placement of Vincent Metzler, Ph.D., as Chief Executive Officer (CEO). Cellcolabs is a Swedish biotechnology company specializing in the large-scale, industrial production o...
AMD, Dell & Univ Cambridge Launch UK AI Innovation Lab (2026-06-10)
From accelerating scientific discovery and advancing healthcare research to transforming public services, AI is becoming a critical driver of innovation and economic growth across the U.K. To help advance the next generation of AI infrastructure and AI-powered scie...
GSK to Acquire Nuvalent for $10.6b in Cash (2026-06-09)
For media and investors only > Multi-product oncology deal for assets that have validated targets and aim to address efficacy and/or tolerability limitations of existing therapies > Includes two late-stage, potential best-in-class ROS1 (zidesamtinib) and ALK ...
AMD Commits up to £2b to Accelerate AI in UK (2026-06-08)
News Highlights: > £2bn investment over five years to support advanced computing, scientific research and workforce development across the United Kingdom. > New strategic partnerships with Imperial College London and Oriole Networks will help advance AI, qua...
DaltonTx Launches Platform and Partners with Sygnature (2026-06-04)
> Dalton is a drug discovery platform integrating agentic AI, human expertise, and experimental data, into one continuous learning engine > Announces collaboration with Sygnature Discovery, a leading integrated drug discovery contract research organisation (CRO)...
Bonito Biosciences and DaltonTx: AI-Driven Collaboration (2026-05-27)
Collaboration combines Bonito’s proprietary functional delivery data engine and ligand discovery platform with DaltonTx’s adaptive AI technology to accelerate precision oligotherapeutic delivery, beginning in the CNS Bonito Biosciences (“Bonito”), a bi...

Life-Sciences-UK.com is your doorway to the British and Irish life sciences!

[LSUK] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the UK and Ireland.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUK] is 100% Made in Germany!

» Start here with the latest News!

Picture EBD Group World of Partnering Opportunities 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)